4.6 Article

The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy

Related references

Note: Only part of the references are listed.
Article Oncology

The impact of COVID-19 on new mesothelioma diagnoses in Italy

Lucia Mangone et al.

Summary: The COVID-19 pandemic had little or no impact on new MM diagnoses in Italy, and the variations were not uniform across the country.

THORACIC CANCER (2022)

Article Medicine, General & Internal

SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care

Mojgan Alaeddini et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2022)

Review Medicine, Research & Experimental

COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges

Simon Moubarak et al.

Summary: The COVID-19 pandemic has had an impact on screening, diagnosis, and management of lung cancer. Medical societies have developed guidelines to protect lung cancer patients from infection and treatment delays. Different therapeutic approaches and international recommendations are being discussed. Healthcare facilities face unique challenges in protecting patients from COVID-19 complications while avoiding delays in treatment.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2022)

Article Pathology

Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic Assessment of the Magnitude of the Problem and Proposals for Corrective Actions

Gerardo Ferrara et al.

Summary: The COVID-19 pandemic in 2020 led to a 44.9% decrease in cancer diagnoses, with skin cancers being the most affected. Decreases in diagnoses were most significant for colorectal, prostate, and bladder cancers, with high-grade prostate tumors showing a moderate impact.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Letter Pathology

Lockdown Measures Negatively Impacted Cancer Care

Sarita Kumari et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Letter Critical Care Medicine

Impact of the COVID-19 Pandemic on Volumes and Disparities in Lung Cancer Screening

Louise M. Henderson et al.

CHEST (2021)

Article Surgery

Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer

Robert M. Van Haren et al.

Summary: The COVID-19 pandemic significantly disrupted lung cancer screening, resulting in a decrease in new patient screenings and an increased proportion of nodules suspicious for malignancy after screenings resumed.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)

Article Oncology

Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection

QuanQiu Wang et al.

Summary: This case-control study found that patients with recent cancer diagnosis were at significantly increased risk for COVID-19 infection and its adverse outcomes, with the strongest association for leukemia, non-Hodgkin lymphoma, and lung cancer. African American cancer patients had a higher risk of COVID-19 infection compared to White patients, highlighting the need for better protection and monitoring strategies.

JAMA ONCOLOGY (2021)

Letter Medicine, General & Internal

Decline in cancer pathology notifications during the 2020 COVID-19-related restrictions in Victoria

Luc te Marvelde et al.

MEDICAL JOURNAL OF AUSTRALIA (2021)

Review Oncology

COVID and Lung Cancer

Luana Calabro et al.

Summary: The COVID-19 pandemic has significantly impacted lung cancer patients, leading to higher susceptibility and mortality rates, challenges in managing patients due to potential interference of anti-tumor drugs on COVID-19 infection, and difficulties in differentiating COVID-19 pneumonitis from drug-related pneumonitis. This has resulted in a profound reshaping of oncological activities and the development of recommendations by the oncology scientific community to prioritize anti-tumor treatments for lung cancer patients.

CURRENT ONCOLOGY REPORTS (2021)

Article Oncology

Cumulative COVID-19 incidence, mortality and prognosis in cancer survivors: A population-based study in Reggio Emilia, Northern Italy

Lucia Mangone et al.

Summary: Despite having higher incidence rate ratios of testing, positive test, and hospitalization and death, cancer survivors had the same probability of being infected, but were at higher risk of death once infected.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer

R. Reyes et al.

Journal of Thoracic Oncology (2021)

Review Oncology

Severity of COVID-19 in patients with lung cancer: evidence and challenges

Antonio Passaro et al.

Summary: Lung cancer patients face unique challenges during the COVID-19 pandemic, and providing them with rational and safe treatment has become a crucial question. Oncologists worldwide have taken action to understand the impact of COVID-19 on cancer patients and have developed guidelines and recommendations accordingly.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study

Ashleigh C. Hamilton et al.

Summary: The restructuring of healthcare systems during the COVID-19 pandemic has led to a significant decrease in cancer diagnoses, particularly for lung, prostate, and gynaecological malignancies. There is a critical need to protect cancer diagnostic services to facilitate timely investigation of potential cancer cases, and targeted public health campaigns may help reduce emerging inequalities in cancer diagnoses.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France

J. Y. Blay et al.

Summary: The study found that the COVID-19 pandemic had a significant impact on cancer patient management at Unicancer comprehensive cancer centers in France, particularly for newly diagnosed patients, affecting more women, breast cancer, prostate cancer, and nonmetastatic cancer patients. Delays in treatment may lead to an increased risk of cancer-related deaths in the coming years.

ESMO OPEN (2021)

Review Oncology

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

Goulnar Kasymjanova et al.

Summary: The impact of COVID-19 on lung cancer diagnosis and treatment has been significant, with a decrease in new diagnoses during the pandemic and a shift towards more advanced stages of disease, increased utilization of radiosurgery, and a decrease in systemic treatment and surgery.

CURRENT ONCOLOGY (2021)

Article Health Care Sciences & Services

The Impact of the COVID-19 Pandemic on Cancer Patient's Management-Lithuanian Cancer Center Experience

Daiva Dabkeviciene et al.

Summary: The COVID-19 pandemic negatively impacted cancer services at the National Cancer Institute of Lithuania, leading to reductions in diagnostic and treatment procedures, decreased patient volumes for medical, radiation, and surgical treatment, and changes in the structure of cancer services. The pandemic also resulted in increased referrals to psychological/psychiatric counselling but a dramatic drop in participation in cancer prevention programs, which may have long-term negative effects on cancer survival rates.

HEALTHCARE (2021)

Article Pharmacology & Pharmacy

Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results

Erika Ruiz-Garcia et al.

Summary: This study evaluated the demographic characteristics, clinical and pathological factors, and outcomes of cancer and COVID-19 patients in Mexico. The findings showed that prognostic factors such as gender, age, active cancer status, and respiratory difficulties can affect the mortality rate and survival time in these patients. The study highlights the importance of identifying these factors for better management of cancer patients with COVID-19.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)

Article Medicine, Research & Experimental

Lung Cancer, Covid-19 Infections and Chemotherapy

Bogdan Haineala et al.

Summary: The study utilized the Teravolt cohort and found a high mortality rate in COVID-19 infected patients with thoracic malignancies. The data indicate challenges in managing lung cancer patients during the COVID-19 pandemic, highlighting the importance of establishing a safe healthcare system and delivering effective clinical services.

IN VIVO (2021)

Review Oncology

Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants

Ludi Yang et al.

Summary: This study found that patients with cancer were more susceptible to COVID-19 and had a higher mortality rate, especially lung cancer patients. The findings suggest that clinicians should pay more attention to cancer patients diagnosed with COVID-19 for their clinical management.

CANCER BIOLOGY & MEDICINE (2021)

Review Oncology

The Impact of COVID-19 Pandemic on Lung Cancer Community

Licun Wu et al.

Summary: The COVID-19 pandemic has significantly impacted lung cancer patients, who are believed to be at higher risk of infection and could see an increase in incidence and mortality. Vaccination is crucial for protecting lung cancer patients, and a better understanding of the SARS-CoV-2 virus could lead to the development of more effective vaccines in the future.

WORLD JOURNAL OF ONCOLOGY (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Editorial Material Oncology

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Wenhua Liang et al.

LANCET ONCOLOGY (2020)

Review Oncology

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer

Eric Raymond et al.

TARGETED ONCOLOGY (2020)

Review Public, Environmental & Occupational Health

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Alfonso J. Rodriguez-Morales et al.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Review Oncology

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

Anne-Marie C. Dingemans et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Article Oncology

Cancer treatment during COVID-19 pandemic

Vishal Jindal et al.

MEDICAL ONCOLOGY (2020)

Editorial Material Medicine, General & Internal

Fair Allocation of Scarce Medical Resources in the Time of Covid-19

Ezekiel J. Emanuel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Oncology

Cancer and COVID-19: Unmasking their ties

A. Addeo et al.

CANCER TREATMENT REVIEWS (2020)

Letter Oncology

Call for ensuring cancer care continuity during COVID-19 pandemic

Marco Tagliamento et al.

ESMO OPEN (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network

Mara Antonoff et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)

Article Oncology

Impact of COVID-19 pandemic on lung cancer treatment scheduling

Kohei Fujita et al.

THORACIC CANCER (2020)

Article Oncology

Chemotherapy and COVID-19 Outcomes in Patients With Cancer

Justin Jee et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Health Care Sciences & Services

The impact of the COVID-19 pandemic on lung cancer patients

Zhou Sha et al.

ANNALS OF PALLIATIVE MEDICINE (2020)

Article Oncology

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study

Abdul Rahman Jazieh et al.

JCO GLOBAL ONCOLOGY (2020)

Article Oncology

Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters

Jack W. London et al.

JCO CLINICAL CANCER INFORMATICS (2020)

Article Cardiac & Cardiovascular Systems

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer

Pamela Samson et al.

ANNALS OF THORACIC SURGERY (2015)